Dae Ho Lee
- Co-authors
- Ticiana LealRaffaele CalifanoBilal PiperdiMartin ReckPerran Fulden YumukLu XuBalazs MedgyasszayOlivier Molinier
- Topics
- Lung Cancer Treatments and Mutations (3 papers)HER2/EGFR in Cancer Research (1 paper)Cancer therapeutics and mechanisms (1 paper)
- Partner nations
- South KoreaUnited StatesUnited Kingdom
In The Last Decade
Dae Ho Lee
5 papers receiving 182 citations
Hit Papers
Peers
Comparison fields: 5 of 21
- Oncology 171
- Pulmonary and Respiratory Medicine 110
- Immunology 33
- Surgery 16
- Cancer Research 13
Countries citing papers authored by Dae Ho Lee
This map shows the geographic impact of Dae Ho Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dae Ho Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dae Ho Lee more than expected).
Fields of papers citing papers by Dae Ho Lee
This network shows the impact of papers produced by Dae Ho Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dae Ho Lee. The network helps show where Dae Ho Lee may publish in the future.
Co-authorship network of co-authors of Dae Ho Lee
This figure shows the co-authorship network connecting the top 25 collaborators of Dae Ho Lee. A scholar is included among the top collaborators of Dae Ho Lee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dae Ho Lee. Dae Ho Lee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 6 | |
| 2 | 6 | |
| 3 | Pembrolizumab Plus Ipilimumab or Placebo for Metastatic Non–Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score ≥ 50%: Randomized, Double-Blind Phase III KEYNOTE-598 Studybreakdown → | 165 |
| 4 | 4 | |
| 5 | 1 | |
| 6 | 0 |
About Dae Ho Lee
Dae Ho Lee is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 6 papers that have together received 182 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (3 papers), HER2/EGFR in Cancer Research (1 paper) and Cancer therapeutics and mechanisms (1 paper). The work is most often cited by research in Oncology (171 citations), Pulmonary and Respiratory Medicine (110 citations) and Immunology (33 citations). Dae Ho Lee has collaborated with scholars based in South Korea, United States and United Kingdom. Frequent co-authors include Ticiana Leal, Raffaele Califano, Bilal Piperdi, Martin Reck, Perran Fulden Yumuk, Lu Xu, Balazs Medgyasszay, Olivier Molinier, Adrian Langleben and Ayman Samkari. Their work appears in journals such as Journal of Clinical Oncology, ESMO Open and Annals of Surgical Treatment and Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.